ClinicalTrials.gg
RecruitingNCT07462741Updated Mar 10, 2026

The Effectiveness of Education in Diabetic Hemodialysis Patients

An interventional study of Diabetic Foot Care Training in Hemodialysis Patient and Diabetes Foot Care, sponsored by Inonu University. Recruiting at 3 sites in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-10.

Sponsored by Inonu University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2026, 8 months ago, but the record still lists the study as recruiting.
  • Started Jan 2026; still recruiting 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 48 studies in Diabetic Foot with a site in Turkey — 14 open to participants now, 18 under way, none of them phase 3. Diabetic Foot · Turkey.

Planned enrollment
31st of 39
50 · median 73
Started
2026
with 3 others
No phase
36 of 48
12 open now
Primary completion
2026-03
later than 12 of 17 live
Registered
43rd of 48
by date

Among the 48 studies in Diabetic Foot with a site in Turkey, this one is the 31st largest by planned enrollment of the 39 interventional ones that give a count, is one of 4 that started in 2026, is one of 36 with no phase, reaches primary completion later than 12 of the 17 other live ones, and was the 43rd registered.

Diabetic Foot

1,079 studies on the registry are indexed under Diabetic Foot; 221 are open to participants now.

Browse Diabetic Foot studies →

Open to participants now

14 of the 48 studies in Diabetic Foot with a site in Turkey are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 139 Diabetic Foot studies recruiting now, 98 (71%) set no upper age limit and 12 (9%) stop at 75 or younger; 5 take children under 18; 11 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 48 studies in Diabetic Foot with a site in Turkey, or all of them as a file.
02

Study summary

Diabetes is a significant health problem affecting approximately half a billion people worldwide, reaching alarming levels. Diabetic foot ulcers are among the most common and serious complications of diabetes. Diabetes is the most common cause of end-stage renal failure, and diabetic nephropathy is identified as a major risk factor for foot ulcers and amputation. The health belief model is a model that explains behavior. Focusing on the necessary motivational resources for the development of positive health behaviors in individuals is crucial for positive patient outcomes in the education of diabetic hemodialysis patients. It is necessary for hemodialysis nurses to educate diabetic patients on foot care knowledge, improve foot care behaviors, and prevent the development of foot ulcers and lower extremity amputations. However, the lack of studies in the literature on nurse-led foot care education interventions based on the health belief model for diabetic patients undergoing hemodialysis constitutes the strength and unique aspect of this study. The research will be conducted using a randomized controlled pretest-posttest design.

Read the detailed description

Diabetes is a significant health problem affecting approximately half a billion people worldwide, reaching alarming levels. Diabetic foot ulcers are among the most common and serious complications of diabetes. Diabetes is the most common cause of end-stage renal failure, and diabetic nephropathy is identified as a major risk factor for foot ulcers and amputation. The health belief model is a model that explains behavior. Focusing on the necessary motivational resources for the development of positive health behaviors in individuals is crucial for positive patient outcomes in the education of diabetic hemodialysis patients. It is necessary for hemodialysis nurses to educate diabetic patients on foot care knowledge, improve foot care behaviors, and prevent the development of foot ulcers and lower extremity amputations. However, the lack of studies in the literature on nurse-led foot care education interventions based on the health belief model for diabetic patients undergoing hemodialysis constitutes the strength and unique aspect of this study. The research will be conducted using a randomized controlled pretest-posttest design. The study population will consist of diabetic hemodialysis patients in the hemodialysis units of Firat University Hospital and Fethi Sekin City Hospital, and in the Private Elazığ Dialysis Center. The sample will consist of 50 individuals in total, 25 for each group (experimental and control) determined by power analysis. Individuals will be randomly assigned to the experimental and control groups. Research data will be collected using a Personal Information Form, the Diabetic Foot Knowledge Scale, the Foot Care Behavior Scale, and the Diabetic Foot Care Self-Efficacy Scale. The research will determine how diabetic foot care training, prepared according to the Health Belief Model, affects the foot care knowledge levels, foot care behaviors, and self-efficacy of diabetic hemodialysis patients. Based on the results obtained, the aim is to increase the importance of foot care in the treatment protocol of diabetic patients in hemodialysis units.

03

Conditions studied

  • Hemodialysis Patient
  • Diabetes Foot Care

Browse trials for

Keywords

  • Diabetic foot
  • patient education
  • hemodialysis
  • self-efficacy
  • health belief model
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Voluntary participation in the study
  • Literacy
  • Absence of psychiatric distress
  • Being over 18 years of age
  • Open to communication and cooperation, no speech problems
  • Receiving continuous hemodialysis treatment
  • Having been diagnosed with diabetes for at least 6 months

Exclusion criteria

Exclusion criteria:

  • Unwillingness to participate in the study or desire to withdraw from the study
  • Receiving acute hemodialysis treatment
  • Being under 18 years of age
  • Open to communication and cooperation, no speech problems
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    group that will receive diabetic foot education

    Group that will receive diabetic foot education

    Other: Diabetic Foot Care Training

  • No intervention
    group that will not receive diabetic foot education

    no intervention will be made on the group

Interventions

  • OtherDiabetic Foot Care Training

    The training will be conducted using an educational booklet prepared in accordance with the Health Belief Model. After collecting pre-test data, the training will be given to the experimental group for 2 weeks, and in order to ensure behavioral change in 4 weeks, reminders about foot care will be given to patients in dialysis centers or by phone, and then the final test data will be applied to both the experimental and control groups. During this process, the control group will continue to receive standard treatment and no intervention will be performed.

06

What researchers measure

Primary outcomes

  1. Evaluation of the effect of diabetic foot care training, prepared according to the Health Belief Model, on the foot care knowledge levels of diabetic hemodialysis patients.

    The Diabetic Foot Knowledge Scale will be used to measure the foot care knowledge levels of the patients.

    Time frame: 6 weeks

  2. Evaluation of the effect of diabetic foot care training, prepared according to the Health Belief Model, on foot care behaviors.

    The Foot Care Behavior Scale will be used to measure foot care behaviors.

    Time frame: 6 weeks

  3. Evaluation of the effect of diabetic foot care training, prepared according to the Health Belief Model, on self-efficacy.

    The Diabetic Foot Care Self-Efficacy Scale will be used to evaluate self-efficacy.

    Time frame: 6 weeks

07

Study locations

3 of 3 sites recruiting
  • Fethi Sekin Şehir Hastanesi
    Elâzığ, Merkez 23000, Turkey (Türkiye)
    Recruiting
  • Fırat Üniversitesi Hastanesi
    Elâzığ, Merkez 23000, Turkey (Türkiye)
    Recruiting
    • fırat üniversitesi hastanesi fırat üniversitesi hastanesi · Contacthastane@firat.edu.tr · 04242333555
  • Özel Elazığ Diyaliz Merkezi
    Elâzığ, Merkez 23000, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Mar 2026, 1 month after the start.

Of 243 non-industry interventional studies with no phase under Diabetic Foot, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 37. This study's planned 1 month is below that.

Counting every sponsor, half of 347 studies reached it within 22 months; a quarter within 9 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 1, 2026
First posted
Mar 10, 2026
StartActual
Jan 26, 2026
Primary completionEst.
Mar 9, 2026
CompletionEst.
Mar 9, 2026
Last update
Mar 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07462741
Lead sponsor
Inonu University
Responsible party
Özlem Coşkun Susem (PhD Student, Inonu University) — Principal investigator
First posted
Mar 10, 2026
Start date
Jan 26, 2026
Primary completion
Mar 9, 2026 (estimated)
Completion
Mar 9, 2026 (estimated)
Last update
Mar 10, 2026

Study contacts

özlem cs özlem coşkun susem
Contact
coskunozlm44@gmail.com
05060573533

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion